PL2938623T3 - Wybrane makrolidy o działaniu hamującym pde4 - Google Patents
Wybrane makrolidy o działaniu hamującym pde4Info
- Publication number
- PL2938623T3 PL2938623T3 PL13814988T PL13814988T PL2938623T3 PL 2938623 T3 PL2938623 T3 PL 2938623T3 PL 13814988 T PL13814988 T PL 13814988T PL 13814988 T PL13814988 T PL 13814988T PL 2938623 T3 PL2938623 T3 PL 2938623T3
- Authority
- PL
- Poland
- Prior art keywords
- pde4
- inhibiting activity
- macrolides
- selected macrolides
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12199801 | 2012-12-31 | ||
| EP13158812 | 2013-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2938623T3 true PL2938623T3 (pl) | 2017-03-31 |
Family
ID=49886948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13814988T PL2938623T3 (pl) | 2012-12-31 | 2013-12-27 | Wybrane makrolidy o działaniu hamującym pde4 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9738676B2 (pl) |
| EP (1) | EP2938623B1 (pl) |
| JP (1) | JP6154026B2 (pl) |
| CN (1) | CN104837855B (pl) |
| CA (1) | CA2889251A1 (pl) |
| DK (1) | DK2938623T3 (pl) |
| ES (1) | ES2607638T3 (pl) |
| HK (1) | HK1210618A1 (pl) |
| HU (1) | HUE030196T2 (pl) |
| PL (1) | PL2938623T3 (pl) |
| PT (1) | PT2938623T (pl) |
| WO (1) | WO2014102315A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110051680B (zh) * | 2018-01-19 | 2022-02-18 | 沈阳福洋医药科技有限公司 | 一种用于预防和/或治疗阿尔茨海默病的药物、组合产品及其应用 |
| RU2771046C2 (ru) | 2018-01-19 | 2022-04-25 | Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд. | Применение карримицина или его активных ингредиентов |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001282105A1 (en) * | 2000-08-22 | 2002-03-04 | Basilea Pharmaceutica Ag | New macrolides with antibacterial activity |
| US6995143B2 (en) * | 2002-02-28 | 2006-02-07 | Basilea Pharmaceutica Ag | Macrolides with antibacterial activity |
| WO2006084410A1 (en) * | 2005-02-09 | 2006-08-17 | Basilea Pharmaceutica Ag | New macrolides |
| BRPI0908343A2 (pt) * | 2008-02-08 | 2020-08-18 | Basilea Pharmaceutica Ag | macrolídeos e seu uso |
| JP5769972B2 (ja) * | 2008-02-08 | 2015-08-26 | バジリア ファルマスーチカ アーゲーＢａｓｉｌｅａ Ｐｈａｒｍａｃｅｕｔｉｃａ ＡＧ | Ｐｄｅ阻害により仲介される疾患を処置するためのマクロライド |
| EP2464651B1 (en) * | 2009-08-13 | 2016-04-20 | Basilea Pharmaceutica AG | New macrolides and their use |
-
2013
- 2013-12-27 HU HUE13814988A patent/HUE030196T2/en unknown
- 2013-12-27 US US14/653,928 patent/US9738676B2/en not_active Expired - Fee Related
- 2013-12-27 CN CN201380064602.7A patent/CN104837855B/zh active Active
- 2013-12-27 PT PT138149885T patent/PT2938623T/pt unknown
- 2013-12-27 DK DK13814988.5T patent/DK2938623T3/en active
- 2013-12-27 ES ES13814988.5T patent/ES2607638T3/es active Active
- 2013-12-27 WO PCT/EP2013/078040 patent/WO2014102315A1/en active Application Filing
- 2013-12-27 PL PL13814988T patent/PL2938623T3/pl unknown
- 2013-12-27 JP JP2015550082A patent/JP6154026B2/ja not_active Expired - Fee Related
- 2013-12-27 EP EP13814988.5A patent/EP2938623B1/en not_active Not-in-force
- 2013-12-27 CA CA2889251A patent/CA2889251A1/en not_active Abandoned
-
2015
- 2015-11-18 HK HK15111366.6A patent/HK1210618A1/xx not_active IP Right Cessation
-
2017
- 2017-08-03 US US15/667,894 patent/US10221206B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK2938623T3 (en) | 2017-01-09 |
| PT2938623T (pt) | 2016-11-23 |
| US10221206B2 (en) | 2019-03-05 |
| US20150344515A1 (en) | 2015-12-03 |
| CN104837855B (zh) | 2017-03-01 |
| EP2938623A1 (en) | 2015-11-04 |
| ES2607638T3 (es) | 2017-04-03 |
| CA2889251A1 (en) | 2014-07-03 |
| JP6154026B2 (ja) | 2017-06-28 |
| HK1210618A1 (en) | 2016-04-29 |
| US9738676B2 (en) | 2017-08-22 |
| US20170327525A1 (en) | 2017-11-16 |
| JP2016504343A (ja) | 2016-02-12 |
| CN104837855A (zh) | 2015-08-12 |
| EP2938623B1 (en) | 2016-10-05 |
| HUE030196T2 (en) | 2017-04-28 |
| WO2014102315A1 (en) | 2014-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL254716B (en) | Zinc-lysine conjugate | |
| ZA201503358B (en) | Structure | |
| GB201411223D0 (en) | None | |
| ZA201409034B (en) | Catalysts | |
| GB201319035D0 (en) | Spolier structure | |
| HK1210038A1 (en) | Nanoconstructs with pharmacological activity | |
| EP2904178A4 (en) | RETENTION SYSTEM | |
| EP2834351A4 (en) | ACTIVITY OF METABOLITE MODIFIED BY AN ENZYME | |
| GB201903206D0 (en) | n | |
| HUP1300640A2 (en) | Belt-mounting structure | |
| EP2939081A4 (en) | ORIENTATION OF PERIODIC ACTIVITIES | |
| GB2535261B (en) | Fastened structure | |
| EP2871919A4 (en) | STRUCTURE | |
| EP2891717A4 (en) | Oligonucleotide | |
| GB2500883B (en) | Improved saw-horse | |
| HK1210618A1 (en) | Selected macrolides with pde4-inhibiting activity pde4 | |
| GB2510023B (en) | Retaining assembly | |
| GB2503904B (en) | System design | |
| GB201219483D0 (en) | Helico-airboat | |
| PL2912230T3 (pl) | Konstrukcja geotekstylna | |
| HU4177U (en) | Manger | |
| EP2929195A4 (en) | MOUNTING ARRANGEMENT | |
| GB201410091D0 (en) | None | |
| IL219908A0 (en) | Adjutable construction | |
| ZA201305187B (en) | Improved brattice |